Annual report pursuant to Section 13 and 15(d)

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.24.0.1
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Stock Options      
Beginning balance outstanding (in shares) 700,729 0  
Granted (in shares) 18,796 736,105  
Vested (in shares) (175,175) 0  
Forfeited (in shares) 0 (35,376)  
Ending balance outstanding (in shares) 544,350 700,729  
Vested not exercised (in shares) 175,175    
Weighted-Average Grant Date Fair Value, per share      
Beginning balance outstanding (in dollars per share) $ 4.5 $ 0  
Granted (in dollars per share) 5.3 4.5  
Vested (in dollars per share) 4.5 0  
Forfeited (in dollars per share) 0 4.5  
Ending balance outstanding (in dollars per share) 4.5 4.5  
Vested not exercised (in dollars per share) 4.5    
Weighted-Average Exercise Price, per share      
Beginning balance outstanding (in dollars per share) 9.4 0  
Granted (in dollars per share) 10.6 9.4  
Vested (in dollars per share) 9.4 0  
Forfeited (in dollars per share) 0 9.5  
Ending balance outstanding (in dollars per share) 9.4 $ 9.4  
Vested not exercised (in dollars per share) $ 9.4    
Weighted average remaining contractual life (in years) 8 years 4 months 24 days 9 years 9 months 18 days  
Weighted average remaining contractual life, granted (in years) 9 years 2 months 12 days 9 years 3 months 18 days  
Weighted average remaining contractual life, vested (in years) 8 years 3 months 18 days    
Weighted average remaining contractual life, vested not exercised (in years) 8 years 3 months 18 days    
Granted, intrinsic value $ 0.0 $ 0.1  
Vested Intrinsic value 0.6    
Aggregate Intrinsic value 2.0 $ 0.1 $ 0.0
Vested not exercised, Aggregate intrinsic value $ 0.6